Family Office Briefing on research byNewmark·Jan 17, 2025
Boston Life Sciences Market Report 3Q24
Boston life sciences sector shows signs of venture capital resurgence in 3Q24 — family offices should consider co-GP opportunities with emerging operators.
Key Metrics
| Metric | Value |
|---|---|
| Laboratory Vacancy Rate | 31.6% |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Newmark
Building a thesis around Boston? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.